Cargando…
Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis
Rationale: Statin, the most widely used medication in lowering cholesterol, is also associated with increased risk of type 2 diabetes, but its molecular basis remains unclear. Methods: Mice were injected intraperitoneally with statins alone or in combination with sirtuin (Sirt) 6 activator, and bloo...
Autores principales: | Shi, Min Yan, Bang, In Hyuk, Han, Chang Yeob, Lee, Dae Ho, Park, Byung-Hyun, Bae, Eun Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545997/ https://www.ncbi.nlm.nih.gov/pubmed/33052223 http://dx.doi.org/10.7150/thno.49770 |
Ejemplares similares
-
FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver
por: Kim, Dae Hyun, et al.
Publicado: (2011) -
Genome-wide analysis of FoxO1 binding in hepatic chromatin: Potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis
por: Shin, Dong-Ju, et al.
Publicado: (2012) -
CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis
por: Oh, Kyoung-Jin, et al.
Publicado: (2013) -
GADD45β Regulates Hepatic Gluconeogenesis via Modulating the Protein Stability of FoxO1
por: Kim, Hyunmi, et al.
Publicado: (2021) -
Acute fructose intake suppresses fasting-induced hepatic gluconeogenesis through the AKT-FoxO1 pathway
por: Sato, Tomoki, et al.
Publicado: (2019)